Product Commercialization

Expand into global markets faster with culturally relevant and compliant messaging. Choose centralized content solutions that ensure native-level localized translation, meet varied regulatory requirements on a region-by-region basis, and increase your speed to global launch.

Get in Touch
Person using iPad to analyze metrics

Comprehensive Support for Product Launches and Commercialization Plans

By partnering with TransPerfect, your team will increase preparation efficiency and shorten time to launch. Discover our complete suite of global product launch solutions.

    Digital Marketing

    Obtain strategic guidance on your omnichannel digital marketing efforts and website localization with our TPT Digital solution. Drive visibility to global marketing campaigns and create targeted messaging for your commercialization plan based on the customer journey.

    Learn More

    Translation Services

    We offer powerful technology to enable faster, more accurate translations of your product launch collateral such as app, website, brochure, and e-learning materials. TransPerfect’s GlobalLink TMS automates manual steps, drives consistency through central TMs and linguistic assets, incorporates MT workflows, and offers real-time reporting for greater visibility and control.

    Learn More

    Social Listening

    Meet with experts to review keyword requirements, search terms, and translations. TransPerfect centralizes the review of literature and streamlines the monitoring of all major social channels to understand the global sentiment around your brand.

    Learn More

    Multicultural Marketing Consulting

    Work with TransPerfect’s cultural consultants to identify your target market, how to best adapt existing marketing content, and create original content and materials that will produce the desired results.

    Learn More

    Trusted by Life Sciences Organizations Big and Small

    With TransPerfect’s support, Novartis, Pfizer, and Merck have created an average of more than $5M in savings. Partnering with TransPerfect has significantly reduced their product localization costs and made it possible for their products to launch up to 50% faster than the competition.

    Novartis
    Pfizer logo
    Merck
    Get a Free Consult ›

    Better Product Commercialization Launches by the Numbers

    30 %

    Faster Product Launch Times

    100 %

    Regulatory Compliance

    $ 5 M

    Average Saved by Novartis, Pfizer, and Merck in Product Localization

    Ready to accelerate your product launch and commercialization?

    Get in Touch ›

    News and Thought Leadership

    View industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexities and bring breakthroughs from lab to launch.

    Is AI Ready to Transform COA Development?

    Blog

    AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover patterns that may have been missed through conventional methods alone. At the same time, not every part of clinical development is equally ready for AI-driven automation. In patient-facing areas such as ...

    Is AI Ready to Transform COA Development?
    Webinar

    AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

    Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...
    Webinar

    Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

    Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...
    Blog

    Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

    The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...
    Blog

    5 Common eCOA Migration Issues

    With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages,...
    Checklist

    A Checklist for eCOA Solution Deployment: Best Practices and Considerations

    Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...
    Success Stories

    Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

    This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...